A method for serial tissue processing and parallel analysis of aberrant crypt morphology, mucin depletion, and beta-catenin staining in an experimental model of colon carcinogenesis

Biological Procedures Online

Volumn 12, Issue 1, 2010, Pages 118-130

  McGinley, John N ^a   Thompson, Matthew D ^a   Thompson, Henry J ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

Aberrant crypt foci; Beta catenin; Colon carcinogenesis; Image analysis; Morphometry; Mucin depletion

Indexed keywords

ALCIAN BLUE; BETA CATENIN; METHYLENE BLUE; MUCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CARCINOGENESIS; COLON RESECTION; CONTROLLED STUDY; CRYPT CELL; DIGITAL IMAGING; ENTERITIS; EXPERIMENTAL MODEL; FEMALE; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; NONHUMAN; PROTEIN DEPLETION; QUANTITATIVE ANALYSIS; RAT; STAINING; TISSUE PREPARATION;

ANIMALIA; RATTUS; RODENTIA;

EID: 78649835822     PISSN: 14809222     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12575-010-9032-x     Document Type: Article

References (33)

1. Bird RP (1987) Observation and quantification ofaberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 37:147-151
2. Bird RP, McLellan EA, Bruce WR (1989) Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv 8:189-200
3. Gupta AK, Pretlow TP, Schoen RE (2007) Aberrant crypt foci: what we know and what we need to know. Clin Gastroenterol Hepatol 5:526-533
4. Tudek B, Bird RP, Bruce WR (1989) Foci ofaberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res 49:1236-1240
5. Caderni G, Femia AP, Giannini A, Favuzza A, Luceri C, Salvadori M et al (2003) Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res 63:2388-2392
6. Gupta AK, Pinsky P, Rall C, Mutch M, Dry S, Seligson D et al (2009) Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci. Gastrointest Endosc 70:322-330
7. Mutch MG, Schoen RE, Fleshman JW, Rall CJ, Dry S, Seligson D et al (2009) A multicenter study of prevalence and risk factors for aberrant crypt foci. Clin Gastroenterol Hepatol 7:568-574
8. Corpet DE, Tache S (2002) Most effective colon cancer chemo-preventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency Nutr Cancer 43:1-21
9. Femia AP, Dolara P, Caderni G (2004) Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Carcinogenesis 25:277-281
10. Femia AP, Bendinelli B, Giannini A, Salvadori M, Pinzani P, Dolara P et al (2005) Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose-and time-dependent in the colon of 1, 2-dimethylhydrazine-treated rats. Int J Cancer 116:9-15
11. Femia AP, Dolara P, Luceri C, Salvadori M, Caderni G (2009) Mucin-depleted foci show strong activation of inflammatory markers in 1, 2-dimethylhydrazine-induced carcinogenesis and are promoted by the inflammatory agent sodium dextran sulfate. Int J Cancer 125:541-547
12. Yoshimi N, Morioka T, Kinjo T, Inamine M, Kaneshiro T, Shimizu T et al (2004) Histological and immunohistochemical observations of mucin-depleted foci (MDF) stained with Alcian blue, in rat colon carcinogenesis induced with 1, 2-dimethylhydrazine dihydrochlor-ide. Cancer Sci 95:792-797
13. Paulsen JE, Loberg EM, Olstorn HB, Knutsen H, Steffensen IL, Alexander J (2005) Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat Cancer Res 65:121-129
14. Paulsen JE, Knutsen H, Olstorn HB, Loberg EM, Alexander J (2006) Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice. Int J Cancer 118:540-546 (Pubitemid 43078504)
15. Rijken PJ, Timmer WG, van de Kooij AJ, Van BI, Wiseman SA, Meijers M et al (1999) Effect of vegetable and carotenoid consumption on aberrant crypt multiplicity, a surrogate end-point marker for colorectal cancer in azoxymethane-induced rats. Carcinogenesis 20:2267-2272
16. Bird RP (1995) Further investigation of the effect ofcholic acid on the induction, growth characteristics and stability of aberrant crypt foci in rat colon. Cancer Lett 88:201-209
17. Thompson HJ, McGinley JN, Rothhammer K, Singh M (1995) Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis 16:2407-2411
18. Thompson HJ, McGinley JN, Wolfe P, Singh M, Steele VE, Kelloff GJ (1998) Temporal sequence of mammary intraductal proliferations, ductal carcinomas in situ and adenocarcinomas induced by 1-methyl-1-nitrosourea in rats. Carcinogenesis 19:2181-2185
19. Thompson HJ, Singh M, McGinley J (2000) Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea. J Mammary Gland Biol Neoplasia 5:201-210 (Pubitemid 32045696)
20. McGinley JN, Knott KK, Thompson HJ (2002) Semi-automated method of quantifying vasculature of 1-methyl-1-nitrosourea-induced rat mammary carcinomas using immunohistochemical detection. J Histochem Cytochem 50:213-222
21. Thompson HJ, McGinley JN, Knott KK, Spoelstra NS, Wolfe P (2002) Vascular density profile of rat mammary carcinomas induced by 1-methyl-1-nitrosourea: implications for the investigation of angiogenesis. Carcinogenesis 23:847-854
22. Magnuson BA, Carr I, Bird RP (1993) Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res 53:4499-4504
23. Hirose Y, Kuno T, Yamada Y, Sakata K, Katayama M, Yoshida K et al (2003) Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis 24:107-111
24. Mori H, Yamada Y, Kuno T, Hirose Y (2004) Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis. Mutat Res 566:191-208
25. Femia AP, Dolara P, Giannini A, Salvadori M, Biggeri A, Caderni G (2007) Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis. Cancer Res 67:445-449
26. Magnuson BA, Bird RP (1993) Reduction ofaberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid. Cancer Lett 68:15-23
27. Zhu Z, Haegele AD, Thompson HJ (1997) Effect of caloric restriction on pre-malignant and malignant stages of mammary carcinogenesis. Carcinogenesis 18:1007-1012
28. Caderni G, Giannini A, Lancioni L, Luceri C, Biggeri A, Dolara P (1995) Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis. Br J Cancer 71:763-769
29. Carter JW, Lancaster HK, Hardman WE, Cameron IL (1994) Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumors in the large bowel of 1,2-dimethylhydrazine-treated mice. Cancer Res 54:4304-4307
30. Magnuson BA, South EH, Exon JH, Dashwood RH, Xu M, Hendrix K et al (2000) Increased susceptibility of adult rats to azoxymethane-induced aberrant crypt foci. Cancer Lett 161:185-193
31. Rao CV, Hirose Y, Indranie C, Reddy BS (2001) Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 61:1927-1933
32. Wali RK, Khare S, Tretiakova M, Cohen G, Nguyen L, Hart J et al (2002) Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Cancer Epidemiol Biomarkers Prev 11:1653-1662
33. Gupta AK, Schoen RE (2009) Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans? Curr Opin Gastroenterol 25:59-65